Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR)
SAR 297.0
(-0.34%)
SAR 297.0
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.19 Billion | 2.84 Billion | 2.18 Billion | 2.17 Billion | 1.05 Billion | 1.43 Billion |
| Net Income | 2.04 Billion | 1.79 Billion | 1.5 Billion | 1.12 Billion | 903.27 Million | 801.3 Million |
| Depreciation & Amortization | 312.67 Million | 309.22 Million | 314.79 Million | 317.82 Million | 255.91 Million | 200.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 382.18 Million | 523.42 Million | 151.29 Million | 549.93 Million | -204.95 Million | 302.06 Million |
| Other non-cash items | 452.09 Million | 214.37 Million | 215.36 Million | 182.43 Million | 104.85 Million | 217.41 Million |
| Investing Cash Flow | -3.49 Billion | -1.93 Billion | -1.24 Billion | -755.69 Million | -730.66 Million | -825.67 Million |
| Investments in PPE | -3.49 Billion | -1.51 Billion | -1.25 Billion | -757.69 Million | -732.88 Million | -830.12 Million |
| Acquisitions | -256 Thousand | -126.03 Million | - | - | -2.77 Million | 4.45 Million |
| Investment purchases | -2.55 Million | -300 Million | - | - | -2.77 Million | - |
| Sales/Maturities of investments | - | 30 Million | - | - | 2.77 Million | - |
| Other Investing Activities | 256 Thousand | -30 Million | 6 Million | 2 Million | 5 Million | -161.6 Million |
| Financing Cash Flow | 179.85 Million | -801.12 Million | -630.7 Million | -279.7 Million | -500.88 Million | -380.34 Million |
| Debt repayment | -1.7 Billion | -432.33 Million | -396 Million | -349.7 Million | -471.17 Million | -408.13 Million |
| Dividends payments | -1.43 Billion | -1.13 Billion | -945 Million | -525 Million | -903.36 Million | -788.47 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 3.31 Billion | 768.71 Million | 710.3 Million | 595 Million | 873.64 Million | -18.77 Million |
| Accounts receivables | -202.43 Million | -40.29 Million | -200.61 Million | 530.06 Million | -322.56 Million | 271.41 Million |
| Accounts payables | 326.07 Million | 156.18 Million | 176.96 Million | -27.8 Million | 139.1 Million | 48.87 Million |
| Inventory | -58.18 Million | -83.5 Million | -26.97 Million | -83.96 Million | -28.15 Million | -6.3 Million |
| Other working capital | 316.72 Million | 491.03 Million | 201.91 Million | 131.65 Million | 6.66 Million | -11.92 Million |
| Cash at beginning of period | 2.74 Billion | 2.64 Billion | 2.33 Billion | 1.19 Billion | 1.36 Billion | 1.14 Billion |
| Cash at end of period | 2.62 Billion | 2.74 Billion | 2.64 Billion | 2.33 Billion | 1.19 Billion | 1.36 Billion |
| Capital Expenditure | -3.49 Billion | -1.51 Billion | -1.25 Billion | -757.69 Million | -732.88 Million | -830.12 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -126.6 Million | 103.15 Million | 304.56 Million | 1.14 Billion | -172.45 Million | 228.58 Million |
| Free Cash Flow | -303.91 Million | 1.33 Billion | 929.26 Million | 1.42 Billion | 326.2 Million | 604.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 573.14 Million | 587.63 Million | 2.04 Billion | 525 Million | 582.46 Million | 525.98 Million |
| Depreciation & Amortization | 92.44 Million | 81.85 Million | 312.67 Million | 78.52 Million | 78.07 Million | 78.16 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -660.7 Million | 94.13 Million | 382.18 Million | 453.55 Million | 179.42 Million | -316.34 Million |
| Other non-cash items | 22.95 Million | 15.77 Million | 452.09 Million | 111.71 Million | 106.01 Million | 82.79 Million |
| Investing Cash Flow | -911.06 Million | -1.06 Billion | -3.49 Billion | -790.88 Million | -1.3 Billion | -891.89 Million |
| Investments in PPE | -919.81 Million | -1.06 Billion | -3.49 Billion | -790.88 Million | -1.3 Billion | -890.94 Million |
| Acquisitions | - | - | -256 Thousand | 2.29 Million | -1.6 Million | -950 Thousand |
| Investment purchases | - | - | -2.55 Million | - | -1.6 Million | -950 Thousand |
| Sales/Maturities of investments | - | - | - | - | 3.2 Million | - |
| Other Investing Activities | 8.75 Million | - | 256 Thousand | -2.29 Million | -1.6 Million | 950 Thousand |
| Financing Cash Flow | -388.3 Million | 175.51 Million | 179.85 Million | -208.27 Million | 371.76 Million | -303.53 Million |
| Debt repayment | -67.76 Million | -607.43 Million | -1.7 Billion | -210.22 Million | -793.69 Million | -83.2 Million |
| Dividends payments | -409.5 Million | -402.5 Million | -1.43 Billion | -409.5 Million | -350 Million | -350 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -22.95 Million | -14.73 Million | 3.31 Billion | 411.44 Million | 1.51 Billion | 129.67 Million |
| Accounts receivables | -638.36 Million | 50.43 Million | -202.43 Million | 130.71 Million | 14.04 Million | -190.49 Million |
| Accounts payables | 202.45 Million | 199.67 Million | 326.07 Million | 91.79 Million | 19.47 Million | 31.25 Million |
| Inventory | -66.52 Million | -154.42 Million | -58.18 Million | -6.01 Million | 32.49 Million | -7.33 Million |
| Other working capital | -158.26 Million | -10.49 Million | 316.72 Million | 237.05 Million | 113.41 Million | -149.77 Million |
| Cash at beginning of period | 2.52 Billion | 2.62 Billion | 2.74 Billion | 2.45 Billion | 2.43 Billion | 3.26 Billion |
| Cash at end of period | 1.34 Billion | 2.52 Billion | 2.62 Billion | 2.62 Billion | 2.45 Billion | 2.43 Billion |
| Capital Expenditure | -919.81 Million | -1.06 Billion | -3.49 Billion | -790.88 Million | -1.3 Billion | -890.94 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.18 Billion | -91.11 Million | -126.6 Million | 169.64 Million | 11.89 Million | -824.82 Million |
| Free Cash Flow | -808.62 Million | -266.62 Million | -303.91 Million | 377.91 Million | -358.27 Million | -520.34 Million |
002562
TALN
EPIAF
RILYM
SSAB-B
NEPTF